COVID-19:東大、アビガン中間体/高効率合成法:収率ほぼ100%(動画):  COVID-19: Univ of Tokyo, Avgigan intermediate/highly efficient synthetic method: Yield almost 100%:  COVID-19:东京大学Avgigan中/高效合成方法:收率接近100%

flu, Drugs, Statistics, Pharmaceutical

COVID-19:フィリピン保健省、アビガン治験を開始へ:Around 80 to 100 patients:  DOH allots P18-M for trials of flu drug Avigan as COVID-19 treatment:  DOH分配P18-M用于流感药物Avigan作为COVID-19治疗的试验

flu, Drugs, Pharmaceutical

COVID-19:RDIF/ChemRar、アビガン(ファビピラビル)治験良好:有効性80%以上:  RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial:  RDIF和ChemRar启动Favipiravir临床试验的最终阶段-

flu, Drugs, Pharmaceutical

COVID-19:富士フイルム、AIでコロナ診断支援:CT画像自動解析(動画):  COVID-19: Fujifilm, AI to support corona diagnosis: CT image automatic analysis:  COVID-19:Fujifilm,AI支持电晕诊断:CT图像自动分析

flu, 3DCG, AI, 4 IT

COVID-19:日医工、フサン(ナファモスタット)増産へ:Latus Therapeuticsに提供:  COVID-19: Nichiiko to increase production of Futhan (nafamostat): provided to Latus Therapeutics:  COVID-19:Nichiiko增产Futhan(nafamostat):向Latus Therapeutics提供

flu, Pharmaceutical

Posts navigation